info
Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss
New York Times admits that SNAKE VENOM is used to formulate Big Pharma’s dangerous drugs
0 views
Skip to first unread message
D. Schlenk
May 26, 2022, 12:30:35 PM5/26/22
to
https://www.newstarget.com/2022-05-06-nytimes-admits-snake-venom-big-pharma-drugs.html
New York Times admits that SNAKE VENOM is used to formulate
Big Pharma’s dangerous drugs
05/06/2022
By Ethan Huff
https://www.newstarget.com/wp-content/uploads/sites/43/2022/05/red-rattlesnake-snake-crotalus-ruber-venomous-hissing-1.jpg
The mainstream media is now openly discussing the fact that
many pharmaceutical drugs contain ingredients derived from
the venom of snakes and other reptiles and creatures.
https://archive.ph/6qx4d
In a new feature piece, The New York Times profiled how the
field of venomics is growing. Teasing apart venom proteins
has become Big Pharma’s forte, resulting in the development
of many new drugs. (Related: Check out this piece we
recently published about the burgeoning market for
venom-derived drugs.)
https://naturalnews.com/2022-04-15-big-pharma-snake-venom-develop-drugs-vaccines.html
“A century ago, we thought venom had three or four
components, and now we know just one type of venom can have
thousands,” says Leslie V. Boyer, a professor emeritus of
pathology at the University of Arizona.
https://www.arizona.edu/
“Things are accelerating because a small number of very good
laboratories have been pumping out information that everyone
else can now use to make discoveries. There’s a
pharmacopoeia out there waiting to be explored.”
The Times describes venomics as “modern-day scientific
alchemy,” and that is precisely what it is: The manipulation
and transformation of animal defense materials into drug
“medicines.”
Venom-derived drugs have been around since the 1970s
One venom-derived drug currently being worked on in
Australia is based on extracts from the funnel web spider.
Researchers say this creature’s venom can be used to halt
cell death following a heart attack.
Scientists were able to create a protein called Hi1A that
they say blocks the ability of cells in beating human hearts
to sense acid, “so the death message is blocked, cell death
is reduced, and we see improved heart cell survival,” says
Nathan Palpant, one of the researchers involved with the
project.
If all goes as planned, the funnel web spider-based drug
could be used by emergency medical workers to potentially
improve outcomes in heart transplants by protecting the
donor heart for a longer period of time.
“It looks like it’s going to be a heart attack wonder drug,”
said Bryan Fry, an associate professor of toxicology at The
University of Queensland. “And it’s from one of the most
vilified creatures” in Australia, he added.
https://www.uq.edu.au/
Venomics has been around for several decades, but only
recently has the technology grown to the point that Big
Pharma is able to manipulate it for wide-scale use.
“We can do assays nowadays using only a couple of micrograms
of venom that 10 or 15 years ago would have required
hundreds of micrograms,” Fry added.
“What this has done is open up all the other venomous
lineages out there that produce tiny amounts of material.”
Many different animals produce venom, and each type is
unique. Reptiles, insects, spiders, snails and jellyfish,
among many other creatures, all make it in varying
quantities, and at varying concentrations.
“We are made of protein and our protein has little complex
configurations on it that make us human,” says Boyer, the
founder of the Venom Immunochemistry, Pharmacology, and
Emergency Response Institute, also known as VIPER.
“And those little configurations are targets of the venom.”
The first venom-derived drug to ever hit the market is
called captopril. It was developed in the 1970s from the
venom of a Brazilian jararaca pit viper to treat high blood
pressure.
Another one called exenatide for type 2 diabetes was derived
from the venom of the Gila monster, while still another,
draculin, was developed from vampire bat venom as an
anticoagulant to treat stroke and heart attack.
Right now, the venom of the Israeli deathstalker scorpion is
undergoing clinical trials as a treatment for breast and
colon tumors.
According to Boyer, Arizona is “venom central.” There are
more venomous creatures there than in any other state.
More related news can be found at PharmaSnakes.com.
Sources for this article include:
NYTimes.com
NaturalNews.com
New York Times admits that SNAKE VENOM is used to formulate
Big Pharma’s dangerous drugs
05/06/2022
By Ethan Huff
https://www.newstarget.com/wp-content/uploads/sites/43/2022/05/red-rattlesnake-snake-crotalus-ruber-venomous-hissing-1.jpg
The mainstream media is now openly discussing the fact that
many pharmaceutical drugs contain ingredients derived from
the venom of snakes and other reptiles and creatures.
https://archive.ph/6qx4d
In a new feature piece, The New York Times profiled how the
field of venomics is growing. Teasing apart venom proteins
has become Big Pharma’s forte, resulting in the development
of many new drugs. (Related: Check out this piece we
recently published about the burgeoning market for
venom-derived drugs.)
https://naturalnews.com/2022-04-15-big-pharma-snake-venom-develop-drugs-vaccines.html
“A century ago, we thought venom had three or four
components, and now we know just one type of venom can have
thousands,” says Leslie V. Boyer, a professor emeritus of
pathology at the University of Arizona.
https://www.arizona.edu/
“Things are accelerating because a small number of very good
laboratories have been pumping out information that everyone
else can now use to make discoveries. There’s a
pharmacopoeia out there waiting to be explored.”
The Times describes venomics as “modern-day scientific
alchemy,” and that is precisely what it is: The manipulation
and transformation of animal defense materials into drug
“medicines.”
Venom-derived drugs have been around since the 1970s
One venom-derived drug currently being worked on in
Australia is based on extracts from the funnel web spider.
Researchers say this creature’s venom can be used to halt
cell death following a heart attack.
Scientists were able to create a protein called Hi1A that
they say blocks the ability of cells in beating human hearts
to sense acid, “so the death message is blocked, cell death
is reduced, and we see improved heart cell survival,” says
Nathan Palpant, one of the researchers involved with the
project.
If all goes as planned, the funnel web spider-based drug
could be used by emergency medical workers to potentially
improve outcomes in heart transplants by protecting the
donor heart for a longer period of time.
“It looks like it’s going to be a heart attack wonder drug,”
said Bryan Fry, an associate professor of toxicology at The
University of Queensland. “And it’s from one of the most
vilified creatures” in Australia, he added.
https://www.uq.edu.au/
Venomics has been around for several decades, but only
recently has the technology grown to the point that Big
Pharma is able to manipulate it for wide-scale use.
“We can do assays nowadays using only a couple of micrograms
of venom that 10 or 15 years ago would have required
hundreds of micrograms,” Fry added.
“What this has done is open up all the other venomous
lineages out there that produce tiny amounts of material.”
Many different animals produce venom, and each type is
unique. Reptiles, insects, spiders, snails and jellyfish,
among many other creatures, all make it in varying
quantities, and at varying concentrations.
“We are made of protein and our protein has little complex
configurations on it that make us human,” says Boyer, the
founder of the Venom Immunochemistry, Pharmacology, and
Emergency Response Institute, also known as VIPER.
“And those little configurations are targets of the venom.”
The first venom-derived drug to ever hit the market is
called captopril. It was developed in the 1970s from the
venom of a Brazilian jararaca pit viper to treat high blood
pressure.
Another one called exenatide for type 2 diabetes was derived
from the venom of the Gila monster, while still another,
draculin, was developed from vampire bat venom as an
anticoagulant to treat stroke and heart attack.
Right now, the venom of the Israeli deathstalker scorpion is
undergoing clinical trials as a treatment for breast and
colon tumors.
According to Boyer, Arizona is “venom central.” There are
more venomous creatures there than in any other state.
More related news can be found at PharmaSnakes.com.
Sources for this article include:
NYTimes.com
NaturalNews.com
0 new messages